Yu-chen Kang

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Yu-chen Kang is an author at University of Hong Kong specializing in hepatocellular carcinoma pharmacotherapy, malignant neoplasms, and liver tumor therapy.

Publications per year

2012–2021

Publications

Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC)

Andrew X. Zhu, Olivier Rosmorduc, Jenny Evans et al. · Annals of Oncology · 2012 · 49 citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial

Sai Ho Sin, Jing Wu, Yu-chen Kang et al. · Trials · 2021 · 14 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +10

1–2 of 2